Stock Research for AXGN

AXGN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AXGN Stock Chart & Research Data

The AXGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXGN Due diligence Resources & Stock Charts

The AXGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXGN Detailed Price Forecast - CNN Money CNN View AXGN Detailed Summary - Google Finance
Yahoo View AXGN Detailed Summary - Yahoo! Finance Zacks View AXGN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AXGN Trends & Analysis - Trade-Ideas Barrons View AXGN Major Holders - Barrons
NASDAQ View AXGN Call Transcripts - NASDAQ Seeking View AXGN Breaking News & Analysis - Seeking Alpha
Spotlight View AXGN Annual Report - CompanySpotlight.com OTC Report View AXGN OTC Short Report - OTCShortReport.com
TradeKing View AXGN Fundamentals - TradeKing Charts View AXGN SEC Filings - Bar Chart
WSJ View Historical Prices for AXGN - The WSJ Morningstar View Performance/Total Return for AXGN - Morningstar
MarketWatch View the Analyst Estimates for AXGN - MarketWatch CNBC View the Earnings History for AXGN - CNBC
StockMarketWatch View the AXGN Earnings - StockMarketWatch MacroAxis View AXGN Buy or Sell Recommendations - MacroAxis
Bullish View the AXGN Bullish Patterns - American Bulls Short Pains View AXGN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AXGN Stock Mentions - StockTwits PennyStocks View AXGN Stock Mentions - PennyStockTweets
Twitter View AXGN Stock Mentions - Twitter Invest Hub View AXGN Investment Forum News - Investor Hub
Yahoo View AXGN Stock Mentions - Yahoo! Message Board Seeking Alpha View AXGN Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for AXGN - SECform4.com Insider Cow View Insider Transactions for AXGN - Insider Cow
CNBC View AXGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXGN - OTC Markets
Yahoo View Insider Transactions for AXGN - Yahoo! Finance NASDAQ View Institutional Holdings for AXGN - NASDAQ


Stock Charts

FinViz View AXGN Stock Insight & Charts - FinViz.com StockCharts View AXGN Investment Charts - StockCharts.com
BarChart View AXGN Stock Overview & Charts - BarChart Trading View View AXGN User Generated Charts - Trading View


Latest Financial News for AXGN

AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
Posted on Wednesday May 23, 2018

AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, president and CEO, will present at the Jefferies Global Healthcare Conference in New York City. AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body.


AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board
Posted on Monday May 21, 2018

AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that its Board of Directors has elected Karen Zaderej as Chairman of the Board in addition to her current role as President and Chief Executive Officer (CEO), effective immediately. Zaderej succeeds Jamie M. Grooms, who will remain a Director of the Board. “As the founder of AxoGen, it has been a tremendous privilege to initiate and develop truly revolutionary products that improve quality of life for patients with peripheral nerve damage,” stated Jamie Grooms.


AxoGen, Inc. Announces Closing of Public Offering of Common Stock
Posted on Monday May 14, 2018

AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock, at a price to the public of $41.00 per share. The number of shares sold by AxoGen includes an aggregate of 450,000 shares of common stock offered and sold pursuant to an option granted to the underwriters that was exercised in full. The total net proceeds from the offering for AxoGen are estimated to be approximately $132,463,000, after deducting underwriting discounts and commissions and other estimated offering expenses payable by AxoGen.


AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
Posted on Wednesday May 09, 2018

AxoGen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has priced an underwritten public offering of 3,000,000 shares of its common stock, which was upsized from the previously announced 2,000,000 shares, at a price of $41.00 per share, resulting in gross proceeds (before underwriting discounts and offering expenses) to the Company of approximately $123,000,000. In addition, AxoGen has granted the underwriters a 30-day option to purchase up to an aggregate of 450,000 shares of common stock at the same price. AxoGen intends to use the net proceeds from the proposed offering for long term facility and capacity expansion and general corporate purposes.


Enter a stock symbol to view the stock details.